TETI, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 5.615
EU - Europa 770
AS - Asia 591
SA - Sud America 12
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 6.999
Nazione #
US - Stati Uniti d'America 5.601
IT - Italia 279
SG - Singapore 272
KR - Corea 192
IE - Irlanda 147
CN - Cina 80
DE - Germania 65
UA - Ucraina 49
SE - Svezia 46
GB - Regno Unito 43
RU - Federazione Russa 30
FI - Finlandia 29
FR - Francia 22
BE - Belgio 17
CA - Canada 14
CZ - Repubblica Ceca 12
IN - India 8
NL - Olanda 8
JP - Giappone 7
PK - Pakistan 7
BR - Brasile 6
IQ - Iraq 6
CH - Svizzera 5
KG - Kirghizistan 5
PL - Polonia 5
GR - Grecia 4
HK - Hong Kong 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
CL - Cile 3
AU - Australia 2
IR - Iran 2
LV - Lettonia 2
MY - Malesia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CM - Camerun 1
EG - Egitto 1
EU - Europa 1
IL - Israele 1
KZ - Kazakistan 1
MD - Moldavia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
RO - Romania 1
Totale 6.999
Città #
Wilmington 1.679
Houston 1.054
Woodbridge 995
Chandler 356
Singapore 252
Fairfield 220
Ann Arbor 120
Dublin 114
Rome 113
New York 106
Ashburn 84
Seattle 80
Cambridge 77
Medford 72
Santa Clara 65
Dearborn 52
Lawrence 33
San Diego 29
Beijing 25
Milan 23
Engelhard 21
Moscow 20
Palo Alto 19
Brussels 16
Helsinki 15
Jacksonville 15
Menlo Park 13
London 12
Toronto 12
Boardman 11
Council Bluffs 11
Creede 11
Munich 10
Seoul 10
Guangzhou 9
Zhengzhou 9
Amsterdam 7
Brno 7
Cedarhurst 6
Hefei 6
Lahore 6
Lappeenranta 6
Nanjing 6
St. George 6
Genzano di Roma 5
Manitou Springs 5
Najaf 5
Naples 5
Norwalk 5
Nuremberg 5
Olomouc 5
Wuhan 5
Clearwater 4
Kraków 4
La Veta 4
Los Angeles 4
Minturno 4
Monte Vista 4
Redwood City 4
São Paulo 4
Tokyo 4
Città Sant'Angelo 3
Colorado Springs 3
Kunming 3
Mülheim 3
Saint Louis 3
Shanghai 3
Albano Laziale 2
Amantea 2
Athens 2
Bagnoregio 2
Bari 2
Bratislava 2
Campofranco 2
Camponogara 2
Canberra 2
Caserta 2
Cesano Maderno 2
Cologno Monzese 2
Falls Church 2
Hangzhou 2
Hanoi 2
Hong Kong 2
Hounslow 2
Jinan 2
Kilburn 2
Kuala Lumpur 2
Lecce 2
Modena 2
Nagold 2
Newcastle upon Tyne 2
Padova 2
Palermo 2
Perugia 2
Ponte Buggianese 2
Prescot 2
Riga 2
San Francisco 2
San Mateo 2
Verona 2
Totale 5.973
Nome #
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 443
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 412
Cortical sources of resting state electroencephalographic rhythms probe brain function in naïve HIV individuals 404
Optimal efficacy of interferon-free HCV retreatment after protease inhibitors failure in real life. 389
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens 364
Optimal cure rate by personalized HCV regimens in real-life: a proof-of-concept study 364
Abnormal cortical sources of resting state electroencephalographic rhythms in single treatment-naïve HIV individuals: A statistical z-score index 322
Brain and cognitive functions in two groups of naïve HIV patients selected for a different plan of antiretroviral therapy: A qEEG study 317
Antiretroviral therapy affects the z-score index of deviant cortical EEG rhythms in naïve HIV individuals 300
Corrigendum to “Brain and cognitive functions in two groups of naïve HIV patients selected for a different plan of antiretroviral therapy: A qEEG study” [Clin. Neurophysiol. 127 (2016) 3455–3469]((S1388245716305089)(10.1016/j.clinph.2016.09.001)) 300
Corrigendum to “Abnormal cortical sources of resting state electroencephalographic rhythms in single treatment-naïve HIV individuals: A statistical z-score index” [Clin. Neurophysiol. 127 (2016) 1803–1812] (S138824571501559X) (10.1016/j.clinph.2015.12.007)) 263
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir± ribavirin in HIV/HCV co-infected patients 249
HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBV-coinfected patients on first-line therapy 238
Cerebral Multishell Diffusion Imaging Parameters are Associated with Blood Biomarkers of Disease Severity in HIV Infection 237
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis 234
Abnormal elevation of international normalized ratio in a patient during the coadministration of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide and warfarin: a case report 230
Hepatitis B virus reactivation sustained by a hepatitis B virus surface antigen immune-escape mutant isolate in a patient who was hepatitis B core antibody positive during treatment with sofosbuvir and velpatasvir for hepatitis C virus infection: A case report 225
Remission of an HHV8-related extracavitary primary effusion lymphoma in an HIV-positive patient during antiretroviral treatment containing dolutegravir 180
Long-Term SARS-CoV-2 Infection Associated with Viral Dissemination in Different Body Fluids Including Bile in Two Patients with Acute Cholecystitis 107
Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab 91
Long-term SARS-CoV-2 infection associated with viral dissemination in different body fluids Including bile in two patients with acute cholecystitis 90
Highly Sensitive HBsAg, Anti-HBc and Anti HBsAg Titres in Early Diagnosis of HBV Reactivation in Anti-HBc-Positive Onco-Haematological Patients 87
Cryptic HBV replicative activity is frequently revealed in anti-HBC-positive/hbsag-negative patients with HIV infection by highly sensitive molecular assays, and can be predicted by integrating classical and novel serological HBV markers 82
B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications 66
Poor CD4/CD8 ratio recovery in HBcAb-positive HIV patients with worse immune status is associated with significantly higher CD8 cell numbers 64
In patients with severe COVID-19, the profound decrease in the peripheral Bblood T-cell subsets is correlated with an increase of QuantiFERON-TB Gold Plus indeterminate rates and reflecting a reduced interferon-gamma production 63
Disruption of brain network organization in patients with human immunodeficiency virus (HIV) infection 60
Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in {SARS}-{CoV}-2 infected patients: a single center study 58
Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b 57
Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing 55
T-cell responses to SARS-CoV-2 in Multiple Sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-Spike antibody titers 52
B- and T-Cell Responses After {SARS}-{CoV}-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications 52
Bictegravir/emtricitabine/tenofovir alafenamide ensures high rates of virological suppression maintenance despite previous resistance in PLWH who optimize treatment in clinical practice 49
Validation of the T-Lymphocyte Subset Index (TLSI) as a Score to Predict Mortality in Unvaccinated Hospitalized COVID-19 Patients 47
Functional brain network reorganization in HIV infection 47
HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA After Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort 45
Cerebral Multishell Diffusion Imaging Parameters are Associated with Blood Biomarkers of Disease Severity in HIV Infection 43
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C 43
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 35
Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab 35
Role of HBcAb Positivity in Increase of HIV-RNA Detectability after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Months 48 Results of a Multicenter Italian Cohort 33
Circulation of sars-cov-2 variants in central Italy: spike variability characterization by deep-sequencing. 33
Remdesivir Influence on SARS-CoV-2 RNA Viral Load Kinetics in Nasopharyngeal Swab Specimens of COVID-19 Hospitalized Patients: A Real-Life Experience 27
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program 26
Hepatitis B-related hepatic flare during immune reconstitution syndrome after antiretroviral treatment initiation in an HBV surface antigen-positive patient with HIV: viroimmunological and histological characterization 24
HUMAN ENDOGENOUS RETROVIRUSES EXPRESSION CORRELATES WITH HIV RESERVOIR, LYMPHOCYTES ACTIVATION AND LOW CD4 COUNT IN VIROLOGICALLY SUPPRESSED PATIENTS 24
HIV DNA viral reservoirs in blood and gut-associated lymphoid tissues (GALT): Implications of switch from triple antiretroviral therapy (ART) to 2-drug dolutegravir/lamivudine regimens 24
HDV replicative activity parallels the production of the three HBsAg forms (Large, Middle and Small HBsAg) and its pathogenetic impact is exacerbated by concomitant HBV replication 22
The transactivation of endogenous retroviruses correlates with HIV reservoir, lymphocytes activation and low CD4 count in virologically suppressed patients 21
The Impact of Viral and Bacterial Co-Infections and Home Antibiotic Treatment in SARS-CoV-2 Hospitalized Patients at the Policlinico Tor Vergata Hospital, Rome, Italy 21
An in-depth characterization of VOCs circulation by using NGS analysis of the Spike protein. 21
Prevalence of HDV infection in Central Italy has remained stable across the last two decades with dominance of sub-genotypes 1 and characterized by elevated viral replication 20
Increased Mild Vaccine-Related Side Effects and Higher Specific Antibody Titers in Health Care Workers with Previous SARS-CoV-2 Infection after the mRNA BNT162b2 Vaccine 20
Resistance to Ceftazidime/Avibactam in Klebsiella pneumoniae KPC-Producing Isolates: A Real-Life Observational Study 18
Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage. 18
Persistence of circulating CD169+monocytes and HLA-DR downregulation underline the immune response impairment in PASC individuals: the potential contribution of different COVID-19 pandemic waves 14
Thymosin alpha 1 restores the immune homeostasis in lymphocytes during Post-Acute sequelae of SARS-CoV-2 infection 11
PATHWAYS UNDERLYING HDV PERSISTENCE ACT INDEPENDENTLY FROM THE EXTENT OF HBV RESEVOIR AND ARE SUSTAINED BY AN ABUNDANT PRODUCTION OF HBSAG DERIVED FROM INTEGRATED HBV-DNA P 214 10
The intrahepatic activity of Hepatitis Delta virus is sustained by an abundant production of HBs transcripts, mainly derived from integrated HBV-DNA, and is not strictly related to the extent of HBV reservoir 10
null 4
Totale 7.200
Categoria #
all - tutte 24.406
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.406


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.423 0 0 88 169 162 176 170 147 165 136 102 108
2020/20211.100 109 109 113 116 101 150 154 134 30 30 34 20
2021/2022567 40 33 33 40 3 64 36 62 77 48 25 106
2022/2023875 87 88 76 106 76 151 52 97 85 3 39 15
2023/2024491 55 9 46 30 35 111 18 15 7 82 11 72
2024/2025523 89 280 154 0 0 0 0 0 0 0 0 0
Totale 7.200